CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE

CLINICAL AND DIAGNOSTIC VALUE OF STUDIES OF ENDOTHELIAL DYSFUNCTION MARKERS IN PATIENTS WITH ISCHEMIC HEART DISEASE

In this paper we have carried out the diagnosis of the damage of the vascular endothelium in patients with ischemic heart disease (IHD) based on the study of gene of endothelial nitric oxide synthase polymorphism, the condition of vasoregulating function of endothelium, endothelin-1 and the level of...

Full description

Bibliographic Details
Main Authors:	A. Kh. Akhmineeva, O. S. Polunina, L. P. Voronina, I. V. Sevostyanova
Format:	Article
Language:	Russian
Published:	Ministry of Healthcare of the Russian Federation. “Kuban State Medical University” 2014-02-01
Series:	Кубанский научный медицинский вестник
Subjects:	ишемическая болезнь сердца полиморфизм гена эндотелиальной синтазы оксида азота эндотелин-1 натрийуретический пептид типа с эндотелиальная дисфункция ischemic heart disease gene of endothelial nitric oxide synthase polymorphism endothelin-1 type c of natriuretic peptide endothelial dysfunction
Online Access:	https://ksma.elpub.ru/jour/article/view/7

Similar Items

BIOCHEMICAL AND GENETIC ASPECTS OF THE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION COMBINATION
by: O. S. Polunina, et al.
Published: (2014-02-01)

Endothelial dysfuncton and 2 type diabetes: novel markers for earlier diagnostics
by: I. A. Khripun, et al.
Published: (2016-10-01)

PROGNOSTIC SIGNIFICANCE OF THE VNTR POLYMORPHISM INTRON 4 OF THE GENE OF NITRIC OXIDE ENDOTHELIAL SYNTHASE IN CHRONIC HEART FAILURE PATIENTS
by: E. A. Polunina, et al.
Published: (2018-02-01)

Особенности механизмов NO-опосредованной дилатации пиальных артерий на воздействие ацетилхолина у стареющих крыс
by: Оксана Петровна Горшкова
Published: (2022-11-01)

ПОЛИМОРФИЗМ ГЕНА ЭНДОТЕЛИАЛЬНОЙ СИНТАЗЫ ОКСИДА АЗОТА И САХАРНЫЙ ДИАБЕТ 2 ТИПА (литературный обзор)
by: Ю. А. Сорокина, et al.
Published: (2014-12-01)

Endothelial dysfunction and its correction with perindopril therapy in patients with coronary heart disease
by: O. A. Vartanova, et al.
Published: (2008-06-01)

The influence of catalaza gene polymorphism on the development of cardiovascular pathology in chronic obstructive pulmonary disease
by: T A Uklistaya, et al.
Published: (2012-12-01)

THE RELATIONSHIP BETWEEN THE LEVEL OF SUPEROXIDDISMUTASE AND THE COEFFICIENT OF ENDOTHELIAL FUNCTION AT RESPIRATORY-CARDIAC COMORBIDITY
by: O. S. Polunina, et al.
Published: (2014-02-01)

НЕКОТОРЫЕ ПАРАМЕТРЫ АТЕРОГЕНЕЗА У БОЛЬНЫХ АНЕМИЯМИ
by: В. Г. Желобов, et al.
Published: (2014-12-01)

Diagnostic assessment of endothelial function in metabolic syndrome and coronary heart disease
by: V. A. Nevzorova, et al.
Published: (2011-04-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

Pathogenetic features of endothelial dysfunction at respiratory-cardiac comorbidity
by: A. Kh. Akhmineeva, et al.
Published: (2014-08-01)

Methods for diagnosing endothelial dysfunction
by: A. V. Shabrov, et al.
Published: (2021-07-01)

Arterial endothelial dysfunction and its role for prognosis assessment in cardiovascular patients
by: G. N. Soboleva, et al.
Published: (2010-04-01)

Role of nitric oxide and endothelial NO synthase in carcinogenesis
by: V. P. Deryagina, et al.
Published: (2021-07-01)

Pharmacological correction of plasma redox potential and endothelial dysfunction in ischemic heart failure
by: O. P. Donetskaya, et al.
Published: (2012-02-01)

RETRACTED: Arginase II - a new target in the development of endothelium protectors
by: V. I. Yakushev, et al.
Published: (2018-02-01)

THE STATE OF NITROXIDE PRODUCTION FUNCTION OF ENDOTHELIUM AND LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2017-08-01)

ПРИМЕНЕНИЕ МЕТОДА ЭКСТРАКОРПОРАЛЬНОЙ АУТОГЕМОМАГНИТОТЕРАПИИ С ЦЕЛЬЮ КОРРЕКЦИИ ГЕМОДИНАМИЧЕСКИХ НАРУШЕНИЙ В ИНТРАОПЕРАЦИОННОМ ПЕРИОДЕ ПРИ ПРОВЕДЕНИИ КОРОНАРНОГО ШУНТИРОВАНИЯ В УСЛОВИЯХ ИСКУCСТВЕННОГО КРОВООБРАЩЕНИЯ
by: К. О. Кротков, et al.
Published: (2024-03-01)

Endothelial dysfunction and prognosis after coronary interventions in patients with coronary heart disease and arterial hypertension
by: M. V. Kazak, et al.
Published: (2011-10-01)

ЗНАЧЕНИЕ N-КОНЦЕВОГО МОЗГОВОГО НАТРИЙУРЕТИЧЕСКОГО ПЕПТИДА У БОЛЬНЫХ ХРОНИЧЕСКОЙ РЕВМАТИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА
by: O. V. Petrova, et al.
Published: (2015-10-01)

Эндотелий - ключ к решению проблемы кардиоваскулярных заболеваний, так или нет?
by: Андрей Сергеевич Галенко, et al.
Published: (2022-02-01)

THE INVOLVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN THE PATHOGENESIS OF CHRONIC GLOMERULONEPHRITIS
by: T.V. Margieva, et al.
Published: (2006-03-01)

The polymorphism c677t of the gene MTHFR correlates with the complications of the coronary heart disease and arterial hypertension for the patients with dislipidaemia
by: G I Myandina, et al.
Published: (2012-06-01)

Endothelial dysfunction role in atherosclerosis pathogenesis
by: E. N. Vorobyeva, et al.
Published: (2006-12-01)

ENDOTHELIAL DYSFUNCTION IN STABLE ANGINA AND MYOCARDIAL INFARCTION COMBINED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: M. A. Popova, et al.
Published: (2015-12-01)

CLINICAL IMPORTANCE OF ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE SYNDROME IN PATIENTS WITH GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION
by: N. N. Kushnarenko, et al.
Published: (2015-09-01)

Pharmacogenetics of HMG-CoA reductase inhibitors (statins): perspectives of individualized, genotype-based therapy
by: D. A. Sychev, et al.
Published: (2006-02-01)

Vascular endothelial dysfunction and comorbid conditions in bronchial asthma
by: A. Kh. Akhmineeva, et al.
Published: (2014-04-01)

Asymmetric dimethylarginine and NO metabolites in patients with acute and chronic coronary heart disease
by: A. S. Galyavich, et al.
Published: (2009-02-01)

CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION
by: N. P. Lyamina, et al.
Published: (2015-12-01)

Relation of smoking and endothelial dysfunction markers in systemic hypertension
by: V. I. Podzolkov, et al.
Published: (2018-10-01)

The study of flow-mediated vasodilation of the brachial artery and other markers of endothelial function in children with familial hypercholesterolemia
by: L. F. Galimova, et al.
Published: (2020-11-01)

Right heart remodeling in coronary heat disease: clinico-pathophysiological correlations
by: N. S. Buslenko, et al.
Published: (2005-10-01)

FEATURES OF THE CLINICAL SIGNIFICANCE OF POLYMORPHIC VARIANTS OF ENOS AND AGTR2 GENES IN PATIENTS WITH CAD
by: A. L. Khokhlov, et al.
Published: (2016-06-01)

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

Comparison of endothelial function in patients with Stage I-II arterial hypertension and stable angina, receiving various bradycardic agents and perindopril
by: L. L. Kirichenko, et al.
Published: (1970-01-01)

METABOLIC STATUS OF VASCULAR ENDOTHELIUM IN PULMONARY TUBERCULOSIS PATIENTS WITH CONCURRENT DIABETES
by: G. O. Kaminskaya, et al.
Published: (2015-10-01)

Effect of combination antihypertensive therapy on the endothelial function in women with hypertension in perimenopause
by: Y. V. Brytkova, et al.
Published: (2013-12-01)